Development of RapidFire Native Mass Spectrometry and Collision Induced Unfolding Methodologies for High Throughput Screening of Protein and Oligonucleotide Biotherapeutics.
Development of RapidFire Native Mass Spectrometry and Collision Induced Unfolding Methodologies for High Throughput Screening.
RECORD
|
Already taken place Tu, 17.10.2023
Agilent Technologies
Untargeted versus Targeted Imaging
We will look at the differences between untargeted and targeted MS imaging.
RECORD
|
Already taken place Tu, 17.10.2023
Waters Corporation
Introduction to USP 1220 Analytical Procedures Life Cycle and Implications of ICH Q14 and Q2(R2) Guidelines
Analytical quality by design (AQbD) principles and the evolution of QbD in the pharmaceutical development environment.
RECORD
|
Already taken place Tu, 17.10.2023
Agilent Technologies
Back to Basics – IC-MS
The basics of why Ion Chromatography coupled with Mass Spectrometry (IC-MS) can be an added benefit to any High-Performance Liquid Chromatography.
RECORD
|
Already taken place Tu, 17.10.2023
Thermo Fisher Scientific
Advances in Proteomics & Metabolomics 2023 - Day 2
Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place Th, 12.10.2023
Technology Networks
Streamlined mAb Subunit LC-MS Workflow for Multiple Attribute Monitoring of Biosimilar mAb Candidates During Bioprocessing and Development
Hear a customer perspective on deploying Waters solutions to enhance biosimilar development.
RECORD
|
Already taken place Th, 12.10.2023
Waters Corporation
Advances in Proteomics & Metabolomics 2023 - Day1
Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place We, 11.10.2023
Technology Networks
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays.
RECORD
|
Already taken place Tu, 10.10.2023
Agilent Technologies
What is Mass Spectrometry Imaging?
We will examine the types of MS imaging techniques on the market and the platforms on which they can be run.
RECORD
|
Already taken place Tu, 10.10.2023
Waters Corporation
Live from the Lab
Learn about the new Thermo Scientific Orbitrap Astral mass spectrometer and discover how it can unleash the proteomics potential of your laboratory.